Background Trajectories of mortality after primary implantable cardioverter-defibrillator (ICD)
placement for older patients with heart failure during or soon after acute hospitalization have …

Background Low plasma potassium (pK) is associated with increased risk of malignant
arrhythmia and observational studies indicate protective effects of pK in the upper reference …

Background The decision to initially implant an implantable cardioverter-defibrillator (ICD) is
informed by robust randomized controlled trials, but no such data exist to guide the decision …

Objectives This study sought to estimate the temporal development in rates and incidences
of appropriate and inappropriate implantable cardioverter-defibrillator (ICD) therapy and …

Data are limited regarding the characteristics and outcomes of patients with cancer who are
found eligible for primary defibrillator therapy. We performed a single-center retrospective …

Background: There is limited data on the impact of comorbidity burden on clinical outcomes
of patients undergoing cardiac implantable electronic devices (CIED) implantation …

Background: Atrial arrhythmias are common in patients with implantable cardioverter-
defibrillator (ICD). External shocks and internal cardioversion through commanded ICD …

Abstract Background The Heart Failure (HF) Meta-score may be useful in predicting
prognosis in patients with primary prevention cardiac resynchronization defibrillators (CRT …

Aims The safety of omitting implantable cardioverter-defibrillator (ICD) generator
replacement in patients with no prior appropriate therapy, comorbid conditions, and …

Purpose The purpose of this study was to assess the available mortality risk stratification
models for implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy …